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Abstract
Background: Third world breast cancer is characterized by late presentation, occurrence at
relatively young ages and dismal mortality. This poor outcome has encouraged patients to
patronize quacks and alternative healers. Public control measures have targeted mainly public
education and provision of screening facilities. Recent reports from the developed world indicate
a high association with obesity, tobacco and alcohol, habits which though not currently very
popular in the third world are nevertheless increasingly accepted.
Methods: A prospective study initiated in 1985 for all breast cancer patients attending 4 hospitals
located in the Eastern Nigeria heartland where the author practiced. On attendance to hospital
detailed epidemiological data including social habits were collected from patients.
Results: Reports from our first series [1987–97] showed some improvement in terms of earlier
presentation compared to a historical control of earlier reports from the sub-region. Reports from
the present study showed that this improvement has not been maintained probably as a result of
diversion of public health campaign finances to HIV/AIDS. However there is an increasing mean age
of presentation due to a higher representation of above 70 years age group and a significant
reduction in parity. Alcohol intake and smoking have remained at low levels among the patients.
Conclusion: There is need to take another look at cancer public health campaign mechanisms in
the face of competing demands from HIV. Public control measures should include among others
teaching of Breast Self Examination [BSE] to patients, Clinical Breast Examination [CBE] to health
workers and opportunistic CBE to all patients. Strenuous efforts should be made to break the
vicious cycle of late presentation, poor treatment outcome and reluctance of patients to present
to health facilities because of poor outcome.
Background
Breast cancer is now the most common female malig-
nancy world-wide with up to a million cases annu-
ally[1,2]. Areas of greatest incidence have been N. America
and Europe with black Africa considered an area of low
incidence[2]. Studies from Nigeria indicate breast cancer
has recently overtaken cervical cancer as the commonest
female malignancy in areas of Western and Eastern
Nigeria[3]. In other parts of the world racial incidence
rates have changed due from migration and adoption of
'Western' life-style [4-6]. General worldwide mortality
rates have decreased as a result of earlier detection, more
favourable stage distribution and improved manage-
ment[7]. However while the decline is marked for
younger patients, moderate for middle-aged, the rates in
elderly women have shown some increase[8]. In the third
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advanced stages and with worse biologic behavior[9,10].
Reasons for late presentation are believed to be due to
ignorance, superstition, self-denial, fear of mastectomy
and unavailability of treatment facilities[7,10-12]. Recent
approaches have targeted public health awareness cam-
paigns to encourage earlier diagnosis. These public aware-
ness started in earnest in Nigeria in mid-80's and were
spear-headed by Nigeria Cancer Society and other agen-
cies. However due to the current HIV/AIDS pandemic
most public health campaign resources are being diverted
to that sector. We established a breast unit in 1987 to
study aspects of the disease in parts of Eastern Nigeria.
Our initial experiences in first ten years showed some
moderate improvement from earlier reports in terms of
earlier presentation and reduced mortality rates[13]. We
decided to present our later experiences to review aspects
of disease bearing in mind increasing 'Westernization' of
the society and the decrease in public awareness cam-
paigns.
Methods
All consecutive patients with breast disease referred to the
authors practices at Nnamdi Azikiwe University Teaching
Hospital, Nnewi [public patients] and Ace Specialist Hos-
pital, Onitsha [private patients] all in Anambra State of
Nigeria were enrolled. Information obtained included
age, sex, marital status, educational and social status,
menarche, menopause, lactation, social habits like smok-
ing and alcohol intake, examination findings including
obesity, tumour assessment and staging, histologic stud-
ies, treatment and outcome. Data were extracted for anal-
ysis including comparison with our initial experiences of
1987–97 and to other published data from Nigeria.
Assessment of metastasis was limited to clinical examina-




During the period 1998–2005 [8 years] 179 new cases of
primary female breast cancer were seen. The age range was
17 to 80 years with a mean of 46.85 years [SD 12.98, SEM
1.45]. The peak age ranges were 30–39 and 40–49. Less
than 10% of patients were aged less than 30 years and
more than 70 years respectively. The mean ages of private
and p ublic hospital patients were 48.2 and 46.2 years
respectively. The age distribution is shown in Fig. 1.
Age distributionFigure 1
Age distribution.
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tation ranged from 5 days to 9 years. Twelve percent pre-
sented at 1 month and under, 41% between 1 and 6
months, 21% between 6 and 12 months, 17% between 12
and 24 months and 9% at more than 24 months as shown
in Fig. 2.
Eighty-eight percent of patients were married, separated,
widowed or divorced at time of presentation. Mean age at
menarche was 13.67 years [SD 1.61, SEM 0.15], 43% were
menopausal at time of initial consultation; mean age at
menopause was 46.34 years [SD 4.73, SEM 0.43]. Mean
parity was 4.28 [SD 3.00, SEM 0.28], range 0 to 10; 17%
were nulliparous. All parous patients had breastfed their
babies, the total duration ranging from 5 to 216 months.
Ninety-two percent of the patients had never used oral
contraceptives, of the few that used, usage was occasional
in most.
Smoking among patients was not admitted to while alco-
hol intake was limited to social [less than a drink
monthly] drinking in less than 15% of the patients.
Ten percent gave a positive family history of breast cancer
with the sister more often affected followed by cousins.
Past history of breast cancer was obtained in 2 patients,
the longest haven been treated 10 years previously. Sixty
percent of the patients had a minimum of high school
education.
Clinical findings
Forty nine percent each occurred in left and right breasts
respectively while 2% were bilateral. Three percent of the
patients presented with Stage I, 11% in Stage IIA, 14%
with Stage IIB, 32% with Stage IIIA, 36% with Stage IIIB
and 4% with obvious distant metastasis in Stage IV as
shown in Fig. 3. Of course under-staging is possible as
only clinical methods with supportive radiology was uti-
lized. Clinical lymph node positivity was noted in 72%.
There were no mammographically diagnosed cases.
Elderly patients and those from poorer social classes pre-
sented at later stages. Whereas public health education has
resulting in significant down-staging of breast cancer in
other parts of the world, the results from our study when
Delay in hospital presentationFigure 2
Delay in hospital presentation.
         	  
             
            
         ﬀ ﬁ  ﬂ   ﬁ ﬃ  ﬀ   ﬂ  ﬂ   
 ! " # $ % & # ' ( # ' ) *
 + , ! " # $ % -
, +  . ! " # $ % -
 . + . / ! " # $ % -
0
. / ! " # $ % -Page 3 of 6
(page number not for citation purposes)
Journal of Experimental & Clinical Cancer Research 2008, 27:17 http://www.jeccr.com/content/27/1/17compared to previous studies from the same environment
show very marginal improvement (Fig. 4).
The commonest histologic diagnosis was infiltrating duc-
tal carcinoma in 80% followed by intraductal carcinoma
in 7%, mucinous in 4%, lobular in 2% and others includ-
ing a case each of malignant phylloides tumour and squa-
mous cell carcinoma.
Discussion
Compared to our previous series[13] there has been a sig-
nificant increase in hospital incidence of breast cancer.
This is in line with other reports from the third world and
from global incidence studies[2,4,5]. However whether
this increase is due to increasing awareness as suggested
by some workers or reflects a global trend will need pop-
ulation based studies to elucidate. The only population
based study in Eastern Nigeria[14] indicate a prevalence
rate of 0.22% in nuns aged 20 to 68 years. The mean age
at presentation has shown some [non-significant]
increase from 44 years in our previous series to 46.9 years,
a figure that is approaching the Asian and Middle Eastern
population mean of 50[15,16] but still a decade younger
than the Western mean. Our findings indicate that the
slight increase in mean age is due more to a higher repre-
sentation of patients aged above 70 than in previous stud-
ies. This higher representation of above 70 age group is
probably due to hospitals being nearer most communities
or by better care by their children.
Significant delays in presentation still abound with only
12% presenting within 1 month of noticing symptoms.
This shows a marginal increase from 7% noted in our pre-
vious study[13]. This late presentation is universal among
patients in the third world including Asian and Arab
countries. Reasons adduced have included long distances
to hospital, lack of awareness, fear of the consequences,
strong belief in traditional medicine, religious charlatans,
poverty, poor education and fear and denial. Improve-
ment in public health awareness as recommended by oth-
ers will surely help. However most funds by Governments
and donor agencies to sub-Saharan Africa are targeted
towards HIV prevention campaigns. Probably adding
talks on cancer during the talks as part of general health
measures may assist. Indeed poor funding has severely
limited the activities of the Nigerian Cancer Society and
other societies involved in cancer control. Quite worri-
some is the observation that a majority of the patients had
Clinical stage at presentationFigure 3
Clinical stage at presentation.
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out anybody examining their breasts. We cannot but con-
cur with Smith et al[11] that training of relevant staff in
clinical evaluation of both symptomatic and asympto-
matic women, opportunistic screening and organized tri-
als of BSE will help achieve earlier detection in resource –
poor communities. Oluwole et al[17] achieved a marked
reduction in mortality and better conservation after intro-
duction of screening in a poor urban community of Har-
lem in North America.
Coupled with delays in presentation is non-improvement
in the clinical stage at presentation despite the above 60%
literacy level in the society when compared to our previ-
ous studies[9,13,18,19]. With more than 70% presenting
with Stages III and IV and 72% with lymph node positiv-
ity curative therapies become elusive. This gloomy picture
reinforces the negative perception of the disease in the
public and maintains the vicious cycle associated with
cancer in the third world. Unlike parts of Asia[15] where
a small number of cases present early with mammo-
graphic diagnosis, such was not the case in this study.
While mammograms are available in some centres, aware-
ness and necessary skills in interpretation are lacking.
Current studies confirm earlier reports of falling age at
menarche, falling parity and increasing age at meno-
pause[13]. These factors have been implicated in breast
cancer increase in other societies. Although the risk asso-
ciated with oral contraceptives and abortion are still the
subjects of considerable dispute[20] both are uncommon
in the breast cancer population of Nigeria. On a happier
note however other risk factors like alcohol intake,
tobacco and obesity are still uncommon in the breast can-
cer population in this study.
Conclusion
Breast cancer still presents late in the third world with a
widening of the 'mortality gap' Public health enlighten-
ment measures for cancer seem to have fallen victim to the
global war on HIV/AIDS. Radical policies including pub-
lic campaigns with emphasis on BSE and CBE should be
encouraged, while deleterious societal mindsets should be
tackled. It may be wise to set targets for earlier detection to
encourage curative and breast conservation measures.
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Advanced cases on presentationFigure 4
Advanced cases on presentation.
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